Bellevue Group Ag Sarepta Therapeutics, Inc. Transaction History

Bellevue Group Ag

$5.98 Billion
Q2 2024

A detailed history of Bellevue Group Ag transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 252,321 shares of SRPT stock, worth $31.5 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

252,321

Previous 251,521 0.32%

Holding current value

$31.5 Million

Previous $32.6 Million 22.43%

% of portfolio

0.67%

Previous 0.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $90,664 - $131,080	800 Added 0.32%	252,321 $39.9 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $1.33 Million - $2.01 Million	14,235 Added 6.0%	251,521 $32.6 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $300,606 - $557,178	-4,466 Reduced 1.85%	237,286 $22.9 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $4.26 Million - $5.13 Million	41,532 Added 20.74%	241,752 $29.3 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $47.5 Million - $70.2 Million	-446,394 Reduced 69.04%	200,220 $22.9 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $5.48 Million - $7.27 Million	-46,595 Reduced 6.72%	646,614 $89.1 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $6.32 Million - $8.28 Million	-62,689 Reduced 8.29%	693,209 $89.8 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $29 Million - $45.7 Million	-383,557 Reduced 33.66%	755,898 $83.6 Million
Q2 2022 Aug 11, 2022	SELL	$62.69 - $88.44 $733,723 - $1.04 Million	-11,704 Reduced 1.02%	1,139,455 $85.4 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $20.5 Million - $29.3 Million	324,418 Added 39.24%	1,151,159 $89.9 Million
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $19.9 Million - $25.6 Million	257,573 Added 45.25%	826,741 $74.4 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $37.5 Million - $52.6 Million	569,168 New	569,168 $52.6 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $1.41 Million - $1.76 Million	-20,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $27,900 - $51,510	300 Added 1.5%	20,300 $3.26 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $370,710 - $592,379	4,500 Added 29.03%	20,000 $1.96 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $1.19 Million - $2.1 Million	15,500 New	15,500 $2 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $1.02 Million - $1.38 Million	-9,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $384,012 - $546,048	-3,600 Reduced 28.35%	9,100 $1.09 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $38,928 - $59,504	-400 Reduced 3.05%	12,700 $1.39 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $1.51 Million - $2.12 Million	13,100 New	13,100 $2.12 Million

Others Institutions Holding SRPT

# of Institutions

561

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Sarepta Therapeutics, Inc. Transaction History